Your browser doesn't support javascript.
loading
Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
Nayagam, Shevanthi; Chan, Polin; Zhao, Kun; Sicuri, Elisa; Wang, Xiaochun; Jia, Jidong; Wei, Lai; Walsh, Nick; Rodewald, Lance E; Zhang, Guomin; Ailing, Wang; Zhang, Lan; Chang, Joo H; Hou, WeiWei; Qiu, Yingpeng; Sui, Binyan; Xiao, Yue; Zhuang, Hui; Thursz, M R; Scano, Fabio; Low-Beer, Daniel; Schwartländer, Bernhard; Wang, Yu; Hallett, Timothy B.
Afiliação
  • Nayagam S; Section of Hepatology and Gastroenterology, Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, United Kingdom.
  • Chan P; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London,UK.
  • Zhao K; World Health Organization China office, Beijing, China.
  • Sicuri E; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
  • Wang X; Health Economics Group, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
  • Jia J; ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Wei L; National Center for AIDS Control and Prevention (NCAIDS), China Center for Disease Control and Prevention, Beijing, China.
  • Walsh N; Liver Research Center, Beijing Friendship Hospital, Beijing, China.
  • Rodewald LE; Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.
  • Zhang G; World Health Organization regional office for the Western Pacific, Manila, Philippines.
  • Ailing W; World Health Organization China office, Beijing, China.
  • Zhang L; National Immunization Programme, China Center for Disease Control and Prevention, Beijing, China.
  • Chang JH; National Center for Women and Children's Health, China Center for Disease Control and Prevention, Beijing, China.
  • Hou W; World Health Organization China office, Beijing, China.
  • Qiu Y; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
  • Sui B; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
  • Xiao Y; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
  • Zhuang H; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
  • Thursz MR; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
  • Scano F; Department of Microbiology and Infectious Disease Center, Peking University Health Science Center, Beijing, China.
  • Low-Beer D; Section of Hepatology and Gastroenterology, Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, United Kingdom.
  • Schwartländer B; World Health Organization China office, Beijing, China.
  • Wang Y; World Health Organization, Geneva, Switzerland.
  • Hallett TB; World Health Organization, Geneva, Switzerland.
Clin Infect Dis ; 72(5): 743-752, 2021 03 01.
Article em En | MEDLINE | ID: mdl-32255486
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Hepatite B Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2021
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Hepatite B Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2021